Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)

Heart Disease Clinical Trial

— MASTERSCREEN  

Official title:

Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes) Who Participate in Long Distance Endurance Training and Competitions.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02923518
• Other study ID #: 2016/21007
• Status: Completed
• Start date: October 2016
• Est. completion date: November 2017

Study information

• Verified date: August 2018
• Source: LHL Helse
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In 2010 there was published new European recommendations for assessment of adult and elderly men and women, who want to start with physical activity and/or participate in endurance contests. In this study we want to test if a group of people with positive score on a self-reported questionnaire and/or high-risk score in a risk scoring system (NORRISK) have more undetected heart diseases than a control group with no reported or detected risk factors.

Description:

Forty senior athletes between 35 to approximately 80 yrs old with a positive score will be included in one group, and another forty seniors without positive score in a control group. Each of them will be tested with an cardiorespiratory exercise test (CPET) with ECG and examined with echocardiography together with an usual medical examination and blood tests (cholesterol and HbA1c-glucose). Some with symptoms of arrhythmias will be examined by 24-hours Holter-monitoring.

The main purpose of the study is to assess if men and women with a positive score on the questionnaire og NORRISK-screening (risk calculator for coronary heart disease) have more detectable heart diseases than the control group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 86
• Est. completion date: November 2017
• Est. primary completion date: November 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 35 Years to 85 Years

Eligibility

Inclusion Criteria:

> 35 yrs old Master athletes Positive score on symptom based questionnaire or high risk score No known heart disease Participated in long-term endurance competitions

Exclusion Criteria:

< 35 yrs old Known heart disease

Related Conditions & MeSH terms

• Heart Disease
• Heart Diseases

Intervention

Other:
• Questionnaire
Observational study without any intervention described under intervention type

Locations

Country	Name	City	State
Norway	LHL-clinics Feiring	Feiring

Sponsors (1)

Lead Sponsor	Collaborator
LHL Helse

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Differences among two groups of senior athletes in detecting heart diseases by a screening program	Examine if a simple screening program is efficient in detecting heart diseases	One year